Search Within

Angela Kellen Green

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (4)
  2. Department of Pathology and Laboratory Medicine (4)
  3. GDMT, Medicine (4)
  4. GDMT, Pathology and Laboratory Medicine (4)
  5. Graduate Medical Education (4)
  6. Gynecologic Medicine Service (4)

More Groups

People
  1. Britta Weigelt (4)
  2. Carol Aghajanian (4)
  3. Jason Konner (3)
  4. Maria Zlobinsky (3)
  5. Rachel Grisham (3)
  6. Vicky Makker (3)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
Publications
  1. Gynecologic Oncology (2)
  2. International Journal of Gynecological Cancer (1)
  3. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (2)
  2. American Society of Clinical Oncology (1)
  3. Lippincott Williams & Wilkins (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: A comprehensive molecular and pathologic analysis
    Journal Article

    Lam, C.; Zhou, Q.; Aghajanian, C.; Abu-Rustum, N. R.; Mueller, J. J.; Ellenson, L. H.; Green, A. K.; Weigelt, B.; Jungbluth, A. A.; Momeni-Boroujeni, A.
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save